Home/ Stocks/ NXL

Nexalin Technology, Inc. Common Stock

NXL XNAS

$0.35 +0.01 (+4.22%) ▲ 15-min delayed

Open

$0.35

High

$0.36

Low

$0.34

Volume

204.3K

Market Cap

$7.45M

About Nexalin Technology, Inc. Common Stock

Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.

Sector: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS Employees: 8 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$14.9K	$-2,096,837	$-0.11
FY 2025	$301.6K	$-8,222,181	$-0.50
Q3 2025	$18.1K	$-2,276,311	$-0.13
Q2 2025	$70.6K	$-1,580,987	$-0.10

Related Market News

No specific coverage for NXL yet. Check out our latest market news or earnings calendar.

Get NXL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Nexalin Technology, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.